ITOSUnknownSmall-Cap
iTeos Therapeutics, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for iTeos Therapeutics, Inc. (ITOS), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are ITOS insiders buying or selling?
iTeos Therapeutics, Inc. insiders reported 11 open-market buys ($133.9M) and 96 sells ($226.0M) across 107 Form 4 filings — a net selling position of $92.1M.
Source: SEC EDGAR Form 4
Key Statistics (as of Jun 12, 2025)
Total Form 4 filings
107
SEC EDGAR
Insider filers
13
Insider buys (11)
$133.9M
Insider sells (96)
$226.0M
Insider sentiment
Net sellingNet insider flow of $92.1M in net selling.
Recent ITOS insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 12, 2025 | Michel Detheux | Chief Executive Officer | Sale | 104.6K | $10.02 | $1.0M |
| Jun 7, 2025 | Michel Detheux | Chief Executive Officer | Sale | 156.8K | $10.15 | $1.6M |
| Jun 7, 2025 | David Hallal | Director | Sale | 114.7K | $10.15 | $1.2M |
| May 16, 2025 | EcoR1 Capital, LLC | 10% Owner | Purchase | 5.0M | $7.80 | $38.7M |
| May 15, 2025 | Ansbert Gadicke | Other | Sale | 1.0M | $8.06 | $8.3M |
| May 15, 2025 | MPM BIOVENTURES 2018, L.P. | Other | Sale | 630.2K | $8.06 | $5.1M |
| May 15, 2025 | Luke Evnin | Other | Sale | 630.2K | $8.06 | $5.1M |
| Nov 20, 2024 | Matthew Gall | Chief Financial Officer | Purchase | 5.0K | $7.73 | $38.6K |
| Oct 12, 2023 | Matthew Gall | Chief Financial Officer | Purchase | 5.0K | $8.37 | $41.9K |
| Aug 26, 2023 | Joseph Lewis | Other | Sale | 350.0K | $16.26 | $5.7M |
| Jun 10, 2022 | David Hallal | Director | Sale | 29.6K | $20.17 | $597.2K |
| May 12, 2022 | Aaron I. Davis | Director | Sale | 663.0K | $21.04 | $13.9M |
| May 3, 2022 | Aaron I. Davis | Director | Sale | 375.0K | $27.33 | $10.2M |
| Apr 19, 2022 | Michel Detheux | Chief Executive Officer | Sale | 11.5K | $31.87 | $366.5K |
| Mar 25, 2022 | Aaron I. Davis | Director | Purchase | 50.0K | $32.51 | $1.6M |
| Mar 23, 2022 | Michel Detheux | Chief Executive Officer | Sale | 18.4K | $34.17 | $630.0K |
| Mar 19, 2022 | Joseph Lewis | 10% Owner | Sale | 575.2K | $35.25 | $20.3M |
| Mar 15, 2022 | Joanne Jenkins Lager | Chief Medical Officer | Sale | 3.5K | $36.01 | $126.0K |
| Mar 3, 2022 | Yvonne Mcgrath | Chief Scientific Officer | Sale | 10.0K | $36.76 | $367.6K |
| Feb 25, 2022 | Michel Detheux | Chief Executive Officer | Sale | 14.5K | $34.34 | $497.9K |
| Feb 15, 2022 | Joanne Jenkins Lager | Chief Medical Officer | Sale | 3.5K | $35.85 | $125.5K |
| Jan 27, 2022 | Michel Detheux | Chief Executive Officer | Sale | 14.5K | $35.68 | $517.4K |
| Jan 19, 2022 | Joanne Jenkins Lager | Chief Medical Officer | Sale | 3.5K | $39.32 | $137.6K |
| Jan 6, 2022 | MPM BIOVENTURES 2018, L.P. | 10% Owner | Sale | 146.7K | $42.58 | $6.2M |
| Jan 6, 2022 | Luke Evnin | 10% Owner | Sale | 146.7K | $42.58 | $6.2M |
Showing the 25 most recent of 107 Form 4 filings for iTeos Therapeutics, Inc..
Most active ITOS insiders
- Luke Evnin21 filings
- Ansbert Gadicke20 filings
- MPM BIOVENTURES 2018, L.P.19 filings
- Michel Detheux16 filings
- Joanne Jenkins Lager7 filings
Ask anything about ITOS insider activity
Use Trabud's AI agent to query iTeos Therapeutics, Inc.'s Form 4 history in plain English — "Show me ITOS CEO purchases this year" or compare it against any other ticker.
Open the AI agentITOS insider trading FAQ
Are iTeos Therapeutics, Inc. insiders buying or selling?
Across 107 SEC Form 4 filings, iTeos Therapeutics, Inc. (ITOS) insiders reported 11 open-market purchases totaling $133.9M and 96 sales totaling $226.0M. That is a net selling position of $92.1M.
How many insiders trade ITOS stock?
13 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for iTeos Therapeutics, Inc.. The most recent filing was accepted on Jun 12, 2025.
Where does Trabud get ITOS insider trading data?
All ITOS insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.